20 October 2025
LA&HA Uzbekistan Training Centre Officially Announced in Tashkent
A new LA&HA Uzbekistan Training Centre was officially unveiled on October 16th, 2025, during an opening event in Tashkent.
Read more
Breaking News: Fotona Secures NMPA Approval for IncontiLase® in China!
19 March 2025
Fotona has made history as the first laser company to receive NMPA (National Medical Products Administration) approval in China for the treatment of mild and moderate stress urinary incontinence (SUI). This marks a significant step forward in non-invasive gynecological treatments.
The approval covers the “Adjuvant treatment of mild and moderate stress urinary incontinence”, performed using Fotona’s IncontiLase® protocol and its patented Fotona SMOOTH® technology—a laser-based solution designed to strengthen vaginal tissue and improve bladder support.
This milestone reflects growing global recognition of laser therapy as an effective, non-surgical option for improving women's quality of life. A win for innovation and women’s health!
To learn more about IncontiLase® and other advanced minimally invasive gynecological treatments, visit the gynecology section of the Fotona website.
Related news
9 September 2025
A Global Gathering for Laser Excellence: the 2025 Fotona Super Symposium
Nearly 500 global participants gathered in Texas for Fotona’s 2025 Super Symposium, uniting experts to explore innovations and advance patient care.
Read more
19 March 2025
Breaking News: Fotona Secures NMPA Approval for IncontiLase® in China!
Fotona has made history as the first laser company to receive NMPA approval in China for the treatment of mild and moderate SUI.
Read more
